Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new perspective on mesenchymal stem cells and their derivatives in alleviating cerebral ischemia-reperfusion injury dynamically regulating mitochondrial function to remodel the immune network.

Cell death & disease·2026
Same author

Determination of ATP Content in Cells.

Cell proliferation·2026
Same author

Core outcome set for Traditional Chinese Medicine treatment of adult allergic rhinitis: study protocol.

BMJ open·2026
Same author

Isorhamnetin-preconditioned MSC-derived exosomes restore ovarian function by inhibiting ferroptosis in chemotherapy-induced POF.

Stem cell research & therapy·2026
Same author

Time-Controlled Refrigerated Stem Cell Therapy Mitigates Scleroderma Fibrosis via Modulation of Mitochondrial Autophagy and Gut Metabolism.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

A cross-sectional study of multidimensional psychosocial stress and depression risk.

Frontiers in behavioral neuroscience·2026
Same journal

Analysis of strength degradation of coal and rock masses and stability of mined areas under long term immersion environment.

PloS one·2026
Same journal

Biogenic Silver-Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant Staphylococcus aureus.

PloS one·2026
Same journal

Preparation and physicochemical characterization of a biodegradable chitosan/carboxymethyl cellulose hydrogel synthesized in NaOH/urea medium.

PloS one·2026
Same journal

Action-guilt, survivor-guilt, and depression in combat-related PTSD.

PloS one·2026
Same journal

Explainable machine learning for predicting activities of daily living at discharge in stroke patients: A retrospective study using SHAP interpretability.

PloS one·2026
Same journal

Deep learning based two-way feature depiction model for brain tumor detection.

PloS one·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

Efficient feeder-free episomal reprogramming with small molecules.

Junying Yu1, Kevin Fongching Chau, Maxim A Vodyanik

  • 1Advanced Development Programs, Cellular Dynamics International, Inc., Madison, Wisconsin, United States of America. jyu@cellulardynamics.com

Plos One
|March 11, 2011
PubMed
Summary
This summary is machine-generated.

Researchers developed a new method for creating footprint-free induced pluripotent stem cells (iPSCs) from human cells. This improved technique uses specific chemical compounds and feeder-free conditions for efficient iPSC generation, advancing cell therapy potential.

More Related Videos

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System
09:16

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System

Published on: November 8, 2017

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids
10:52

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Published on: June 5, 2015

Related Experiment Videos

Last Updated: Jun 3, 2026

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
08:14

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors

Published on: October 28, 2014

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System
09:16

Efficient Generation and Editing of Feeder-free IPSCs from Human Pancreatic Cells Using the CRISPR-Cas9 System

Published on: November 8, 2017

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids
10:52

Generation of Induced Pluripotent Stem Cells from Frozen Buffy Coats using Non-integrating Episomal Plasmids

Published on: June 5, 2015

Area of Science:

  • Stem Cell Biology
  • Regenerative Medicine
  • Epigenetics

Background:

  • Induced pluripotent stem cells (iPSCs) offer potential for cell transplantation therapies.
  • Current methods for generating footprint-free iPSCs have limitations, including inefficiency and reliance on feeder cells.
  • Previous work established footprint-free iPSC derivation using episomal vectors but lacked efficiency and required feeders.

Purpose of the Study:

  • To significantly enhance the efficiency of episomal reprogramming for footprint-free human iPSC generation.
  • To establish feeder-free reprogramming conditions using chemically defined media.
  • To enable routine derivation of clinical-grade footprint-free human iPSCs.

Main Methods:

  • Utilized a cocktail of small molecule inhibitors (PD0325901, CHIR99021, A-83-01, HA-100) and human leukemia inhibitory factor to boost episomal reprogramming efficiency.
  • Developed feeder-free reprogramming conditions employing chemically defined media supplemented with bFGF and N2B27, as well as mTeSR1.
  • Tested the protocol on human skin fibroblasts, adipose tissue-derived cells, and cord blood cells.

Main Results:

  • Achieved greatly improved efficiency in episomal reprogramming for footprint-free human iPSC derivation.
  • Successfully established feeder-free reprogramming conditions using chemically defined media.
  • Demonstrated routine derivation of footprint-free human iPSCs from multiple primary cell sources.

Conclusions:

  • The enhanced episomal reprogramming method significantly improves efficiency and enables feeder-free derivation of footprint-free human iPSCs.
  • This optimized protocol facilitates the routine production of clinical-grade human iPSCs.
  • The technology holds promise for advancing cell-based therapies and regenerative medicine.